Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04713722

Early Life Stress and Depression: Molecular and Functional Imaging

Status
Recruiting
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
Mclean Hospital · Academic / Other
Sex
Female
Age
20 Years – 32 Years
Healthy volunteers
Accepted

Summary

Severe childhood adversity accounts for a large portion of psychiatric illness, and an increased risk for major depressive disorder (MDD). For some individuals, childhood adversity has negative psychological and medical consequences; others preserve mental and physical health despite such experiences (they are resilient). In spite of this, little is known about the neurobiological mechanisms related to childhood adversity, especially oxidative stress abnormalities in the brain. To fill this gap, this study combines functional, structural, and molecular imaging approaches to examine the role of oxidative stress abnormalities related to childhood adversity.

Detailed description

Epidemiological studies have shown that severe childhood adversity explains 32-44% of psychiatric disorders, and is associated with 4.6-fold risk for MDD later in life. In spite of these epidemiological data, the neurobiological underpinnings associated with maladaptive sequelae of severe childhood adversity as well as resilience remain largely unknown. Preclinical research suggests that early adversity leads to (1) structural abnormalities in brain regions critically implicated in stress regulation; (2) increased oxidative stress; and (3) glutamatergic abnormalities. The current research protocol is designed to prospectively test the contributions of these abnormalities in individuals exposed to severe childhood adversity. Improving our understanding of neurobiological mechanisms associated with different childhood adversity outcomes is of paramount importance in order to (1) identify individuals at risk for psychopathology and maladaptive behavior, (2) prevent re-victimization, and (3) develop more targeted therapeutic interventions.

Conditions

Timeline

Start date
2021-02-01
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2021-01-19
Last updated
2025-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04713722. Inclusion in this directory is not an endorsement.